ROHIT TALWAR, M.D.

Plain English
This study looked at different treatment options for patients with bladder cancer that doesn’t respond to a common therapy, BCG, and who can't or don't want to have surgery to remove the bladder. The researchers found that for patients willing to try only one treatment option, the combination of gemcitabine and docetaxel is the most cost-effective. However, for those open to trying more than one treatment, surgery is the best choice, and for patients wanting to avoid surgery while trying FDA-approved treatments, pembrolizumab offers the best value. This is important because it helps patients and doctors choose the best and most affordable treatments based on individual circumstances. Who this helps: Patients with BCG-unresponsive bladder cancer and their doctors.

Plain English
This research looked at the costs of medications that prevent kidney stones, focusing on how much money could be saved if Medicare used prices from the Mark Cuban Cost Plus Drug Company. The study found that switching to these lower prices could save Medicare between $2.3 million and $15.7 million for allopurinol and up to $26 million for chlorthalidone, among others, making treatment much more affordable. This is important because many patients struggle with high medication costs, and these savings could greatly reduce their financial burden. Who this helps: This helps patients needing medications for kidney stone prevention.

Plain English
This study looked at how well people understand health information related to urologic cancers, such as prostate or bladder cancer. It found that many patients struggle with health literacy, which is important because only 12% of US adults can effectively understand and use health information from their doctors. This matters because better health literacy can lead to improved treatment decisions and overall health outcomes. Who this helps: This helps patients facing urologic cancers by improving their understanding of their health.

Plain English
This study looked at how changes in tobacco taxes and smoke-free laws affect bladder cancer deaths and life quality in the U.S. It found that while there was no overall national impact, 22 states saw significant reductions in bladder cancer deaths, with Arkansas showing a decrease of 3.64%. This is important because it highlights that raising tobacco taxes can help lower cancer-related deaths in some areas over time. Who this helps: Patients at risk of bladder cancer and public health officials.

Plain English
Researchers studied the impact of blood transfusions from donors (known as allogenic blood transfusions) on patients with advanced kidney cancer who underwent surgery. They found that out of 633 patients, those who received transfusions (20%) had significantly worse outcomes: 46% experienced a recurrence of cancer and only 52% survived, compared to 22% recurrence and 83% survival among those who didn't receive transfusions. This matters because it suggests that avoiding these transfusions during kidney surgeries could lead to better survival rates for patients. Who this helps: This helps patients with advanced kidney cancer undergoing surgery.

Plain English
This paper discusses the evolution of the Society of Women in Urologic Oncology (WUO), which started as an informal group meeting at annual events and has become an official organization recognized by the Society of Urologic Oncology. The main goal of the WUO is to improve the recruitment, retention, and advancement of women in the field of urologic oncology. This is important because increasing diversity in this specialty can lead to better patient care and outcomes. Who this helps: This benefits female urologic oncologists and their patients.

Plain English
This study compared two blood-thinning medications, apixaban and enoxaparin, to see which one works better for preventing blood clots in patients after major bladder surgery called radical cystectomy. It looked at how well patients followed their treatment, how satisfied they were, the costs they faced, and the rates of blood clots that occurred. The results showed that both medications are effective, helping doctors choose the best option for their patients. Who this helps: This research benefits patients recovering from bladder surgery.

Plain English
This study looked at the impact of increasing tobacco taxes on smoking rates and bladder cancer (BC) cases in the United States from 1975 to 2019. Researchers found that for every 1% increase in tobacco tax, BC cases dropped by 1.77% over six years, with California seeing the largest decline of 1.98%. This is important because it shows that higher tobacco taxes can lead to lower cancer rates, particularly benefiting public health and reducing the burden of cancer treatment. Who this helps: This helps patients, especially those at risk for bladder cancer, as well as healthcare providers and policymakers focused on cancer prevention.

Plain English
This study looked at how to improve care for women undergoing radical cystectomy, a major surgery to remove the bladder due to bladder cancer. Researchers found that special attention should be given to the female reproductive organs, such as the cervix and uterus, during this procedure to ensure better outcomes for women. This matters because a more careful approach can help women maintain their reproductive health and overall well-being after surgery. Who this helps: This benefits women facing bladder cancer treatment.

Plain English
This study looked at how language and ethnicity affect recovery and feelings of regret in Hispanic men treated for prostate cancer over ten years. Researchers found that Spanish-speaking Hispanic men reported significantly better urinary and bowel function compared to their English-speaking peers, with meaningful differences of 12.4 points for urinary incontinence and 5.1 points for bowel function. Additionally, English-speaking Hispanic men were more likely to regret their treatment decisions, with nearly eight times the odds of regret compared to Spanish-speaking men. Who this helps: This research benefits prostate cancer survivors, particularly Hispanic men, by highlighting the need for tailored support based on language and ethnicity.

Plain English
This research focused on creating new oral medications derived from itaconate, a compound that helps control inflammation in various diseases. The study found that one group of these new medications, called POC-based prodrugs, worked well at reducing inflammation in skin cells and were effectively absorbed when taken orally, releasing important levels of itaconate into the body. This is significant because it can lead to better treatments for skin and systemic disorders, making it easier for patients to receive therapy. Who this helps: Patients with inflammatory skin conditions and related disorders.

Plain English
This study looked at a new payment model for prostate cancer surgery called "bundled payments." It aims to improve the quality of care while controlling costs, which is important because prostate cancer treatment can be expensive and varies greatly in price. The model could potentially lead to better patient outcomes by ensuring that doctors are rewarded for good results while providing fair compensation based on the severity of the disease. Who this helps: This helps patients with prostate cancer and their doctors.

Plain English
This study looked at how telemedicine affected access to cancer care for different racial and ethnic groups during the COVID-19 pandemic. It found that 35.5% of people used telemedicine, but usage was lower among non-Hispanic Black and non-Hispanic Asian individuals compared to non-Hispanic White individuals. However, among cancer patients specifically, these disparities were reduced, with 48.7% using telemedicine. Who this helps: This benefits cancer patients, particularly those from minority groups.

Plain English
This study looked at how limited options for doctors in Medicare Advantage plans affect access to urologic care. It found that while these narrow networks can help keep costs down, they often make it harder for patients, especially in underserved areas, to see urologists. This limited access can worsen health outcomes for people with urologic conditions. Who this helps: Patients needing urologic care.

Plain English
This study looked at different types of tests, called biomarkers, for prostate cancer to see if they can help doctors make better treatment decisions while saving money in healthcare. The findings show that serum tests like 4Kscore and PHI can lower unnecessary biopsies and costs, while urine tests like SelectMDx and EPI are even more cost-effective for detecting prostate cancer. Overall, using these biomarkers can improve patient care and reduce expenses, but challenges with costs and guidelines are limiting their use in clinics. Who this helps: This helps patients with prostate cancer and their doctors.

Plain English
Researchers studied how to block a specific enzyme, malic enzyme 3 (ME3), that helps pancreatic cancer cells survive, especially in cases where certain genetic mutations are present. They found a new compound, called compound 13, that effectively inhibits ME3 and works even better when combined with another cancer drug, trametinib, in lab tests. This approach offers a promising new treatment option for patients with a specific type of pancreatic cancer known as PDAC. Who this helps: Patients with pancreatic cancer.

Plain English
This study looked at how radical cystectomy (a surgery to remove the bladder) affects the support of pelvic organs in women. Researchers found that 96% of the 48 women observed showed increased pelvic organ descent after the surgery, with the average distance from a key support line growing from 2 mm before the surgery to 14 mm after. This finding highlights that many women experience significant changes to their pelvic floor support following cystectomy, which can impact their quality of life. Who this helps: This helps patients who have undergone radical cystectomy, as well as their doctors in understanding potential postoperative complications.

Plain English
This study looked at a treatment called stereotactic ablative body radiotherapy (SABR) for patients with rare forms of cancer that have spread to other parts of the body (called oligometastases). Researchers found that patients treated with SABR had a median overall survival of 40.1 months and a median progression-free survival of 14.2 months, indicating good effectiveness and safety of the treatment. The study also identified that previous radiation therapy and tumor size played a role in how long patients lived after treatment. Who this helps: This research benefits patients with rare primary cancers and their doctors by providing effective treatment options for metastases.

Plain English
This study looked at Grade Group 1 (GG1) prostate cancer, which has become more common since routine screening started. Researchers found that patients with GG1 often experienced unnecessary treatments that harmed their quality of life, even though this type of cancer usually grows very slowly. The findings support treating GG1 with a watchful approach rather than aggressive therapies, suggesting it might be better classified as a non-cancerous condition. Who this helps: This helps patients with Grade Group 1 prostate cancer by reducing unnecessary treatments and improving their quality of life.

Plain English
This study looked at the effects of different treatments for localized prostate cancer on patients' sexual, urinary, bowel, and hormone functions over a decade. Researchers found that men who underwent radical prostatectomy experienced higher rates of urinary incontinence, particularly those with unfavorable-prognosis cancer, where the difference was significant at -26.6 points compared to those receiving external beam radiotherapy with androgen deprivation therapy. These findings are important because they help patients and doctors understand the long-term impacts of treatment options, allowing for better decision-making about care. Who this helps: Patients with localized prostate cancer.

Plain English
This study examined how different urologists manage small kidney tumors in patients aged 66 and older. The researchers looked at data from over 12,000 patients and found that the treatment choices varied widely from one urologist to another: for example, surgery rates ranged from 10.1% to 66.6% for partial nephrectomy, and nonsurgical management varied from 4.9% to 36.1%. This variation suggests that the urologist's preferences significantly influence treatment decisions, highlighting the need for clearer guidelines to ensure consistent and appropriate care for patients. Who this helps: This helps patients with small kidney tumors by promoting more standardized treatment options.

Plain English
This study focused on a 43-year-old man who experienced hearing loss due to a blockage in his Eustachian tube after years of using cocaine. The examination revealed that his Eustachian tube was completely blocked, leading to a condition known as "glue ear." The findings emphasize the need for careful medical assessments in patients with a history of cocaine use, as it can lead to serious complications like this. Who this helps: This information is valuable for doctors treating patients with a history of cocaine use.

Plain English
This study looked at the potential for alternative proteins, like plant-based or lab-grown foods, to meet nutrition needs in low- and middle-income countries. It found that as incomes rise and cities grow, there is a big opportunity for these proteins to enter the market, which could help provide healthier food options while also benefiting the environment. The research highlights the importance of addressing challenges and finding strategies to promote these proteins in these regions to support a growing global population. Who this helps: This helps patients and consumers in low- and middle-income countries by providing healthier food choices.

Plain English
This study looked at how to increase the demand for alternative protein sources, like plant-based options, in low- and middle-income countries. Researchers found that local sourcing, positive messaging, and fitting these proteins into current diets are crucial for getting people to try them. For example, successful projects in Ghana, Ethiopia, and Armenia showed that these factors can help make alternative proteins more popular, which is important for both nutrition and sustainability. Who this helps: This benefits consumers in low- and middle-income countries who need more nutritious food options.

Plain English
This study looked at how well ChatGPT explains common ear, nose, and throat surgeries, specifically tonsillectomy, adenoidectomy, and grommets. The study found that while ChatGPT can make information easier to read—improving readability by 43.6% after simplification—it still provides lower quality information, scoring 11.6% worse than reliable patient leaflets from ENT UK. This is important because patients need clear and accurate information to make informed decisions about their healthcare. Who this helps: This benefits patients who need understandable information about their medical procedures.

Plain English
This study explored ways to help patients reduce their out-of-pocket costs for prescription medications related to urological care. It identified four online tools: the Medicare Part D Plan Finder, GoodRx, Amazon, and the Mark Cuban Cost Plus Drug Company, which can direct patients toward more affordable options. By using these resources, patients can save money on their medications, which is particularly important given the financial strain many face due to high prescription costs. Who this helps: This benefits patients who need affordable medications for urological issues.

Plain English
This study looked at long non-coding RNAs (lncRNAs) in patients with acute myeloid leukemia (AML) to see how they might predict survival and treatment success. The researchers analyzed 27 studies involving over 5,600 patients and found that abnormal lncRNA levels were linked to much worse outcomes, including a more than twofold increased risk of death (HR = 2.05) and shorter disease-free periods (HR = 2.17). These findings show that measuring lncRNA levels can help doctors better understand how patients with AML will respond to treatment. Who this helps: This helps patients with AML and their doctors in making more informed treatment decisions.

Plain English
This study looked at how using deep sedation with a drug called propofol compared to conscious sedation with midazolam affects the success and risks of a medical procedure called endoscopic retrograde cholangiopancreatography (ERCP), which examines the bile and pancreatic ducts. Among 725 patients, the technical success of ERCP was higher with propofol (82%) than with midazolam (75%), but adverse events occurred more frequently in the propofol group (20% vs. 11%). It's important to know this because while propofol may improve the success of the procedure, it also increases the chances of complications like pancreatitis and cholangitis. Who this helps: This information benefits doctors and medical teams making decisions about sedation options for ERCP patients.

Plain English
This research focused on a new treatment for alopecia areata, a condition that causes patchy hair loss due to the immune system attacking hair follicles. The study found that a topical drug called SCD-153 led to significant hair growth in mice, performing better than other treatments like the JAK inhibitor tofacitinib. This is important because existing treatments can have harmful side effects and recurrence of hair loss is common. Who this helps: This helps patients suffering from alopecia areata.

Plain English
This study looked at a program called "One Safe Act" (OSA) designed to improve patient safety in surgical settings by encouraging staff to share and reflect on their proactive safety behaviors. Out of 140 surgical staff members who participated in OSA sessions, 82% believed the activity would change how they approach patient safety, and nearly all felt it strengthened their colleagues' commitment to safe care. This is important because a strong safety culture can reduce risks to patients during surgery and improve overall care quality. Who this helps: Patients undergoing surgery benefit from enhanced safety practices.

Plain English
This study looked at how medical staff in surgical areas actively ensure patient safety through their behaviors. Researchers gathered information from 140 staff members who described 147 different proactive safety actions they took. The results showed that most actions focused on routine adjustments (31%) and resource management (21%), among other areas, highlighting the importance of staff adaptability to keep patients safe during operations. Who this helps: This benefits patients by ensuring a safer surgical experience.

Plain English
This study examined the relationship between a specific measurement in the brain's blood flow (middle cerebral artery peak systolic velocity or MCA PSV) and a heart condition called fetal hypertrophic cardiomyopathy. The researchers found that higher MCA PSV levels could indicate a worse outlook for these patients, suggesting that close monitoring may be needed. This is important because it helps healthcare providers identify those fetuses at higher risk of complications. Who this helps: This helps doctors and healthcare providers in making better decisions for expectant mothers and their babies.

Plain English
This study looked at the potential savings for Medicare if they used cheaper prices from the Mark Cuban Cost Plus Drug Company (MCCPDC) for seven common cancer drugs instead of regular Medicare prices. The researchers estimated that Medicare could save around $661.8 million, with individual patients potentially saving up to $25,200 a year for one drug, abiraterone, and between $17,500 and $20,500 for imatinib. This matters because it shows how providing access to less expensive drugs can significantly lower health care costs for both Medicare and patients. Who this helps: Patients taking cancer medications.

Plain English
This study looked at how the Inflation Reduction Act may affect the out-of-pocket costs for Medicare patients with advanced prostate cancer starting in 2025. Currently, patients face high costs for their medications, ranging from $464 to $11,336 a year. After the new law takes effect, those using certain treatments could save up to $9,336 per year, greatly easing their financial burden and helping about 25,000 patients. Who this helps: This benefits Medicare patients with advanced prostate cancer.

Plain English
This study looked at a scoring system called the RENAL Nephrometry Score, which gauges the complexity of kidney tumors in children undergoing surgery. The researchers found that the score can be reliably applied to pediatric patients and that those with higher scores had longer surgeries (357 minutes compared to 267 minutes) and longer hospital stays, but no increase in complications within 30 days. This matters because using a standardized scoring system can help doctors better understand and manage the risks associated with surgeries for kidney tumors in children. Who this helps: Patients, their families, and doctors treating pediatric kidney tumors.

Plain English
This study examined how effective a specific imaging test, called F-FDG PET/CT, is at finding hidden neck cancer spread in patients with early-stage oral cavity cancer who appear to have no swollen lymph nodes. The researchers found that F-FDG PET/CT accurately identified the presence of hidden cancer in nearly 88% of cases and was able to rule out cancer spread 97% of the time when it returned a negative result. This matters because using this imaging could allow doctors to avoid unnecessary surgeries in about 74% of patients by better identifying those who do not need additional treatment. Who this helps: This helps patients with early-stage oral cavity cancer by reducing unnecessary surgeries and associated risks.

Plain English
This study focused on a specific enzyme called β-1,4-GalT-V and its role in cancer, inflammation, and other diseases. The researchers found that when this enzyme is not properly regulated, it can lead to issues like increased cell growth and migration, driving the progression of diseases such as cancer and heart disease. Understanding how β-1,4-GalT-V affects these processes could pave the way for new therapies that target this enzyme, potentially improving treatment for patients with these conditions. Who this helps: This research benefits patients with cancer, cardiovascular diseases, and other inflammation-related illnesses.